12:00 AM
Aug 19, 2013
 |  BC Week In Review  |  Financial News  |  Completed Offerings

Northwest Biotherapeutics completes direct public offering

Northwest Biotherapeutics Inc. (NASDAQ:NWBO), Bethesda, Md.
Business: Cancer
Date completed: 8/9/13
Type: Direct public offering
Raised: $15 million

Read the full 75 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >